ClinicalTrials.gg
DrugRead study by study

Exemestane clinical trials

Also written Aromasin, FCE-24304 and PNU 155971.

studies test it
117
open now
22
in phase 3
38
first study started
1996
ClinicalTrials.gov finds 400 studies for exemestane. How that becomes 117 hereChecked on ClinicalTrials.gov

Every study that search finds has been read, apart from the 1 newest, to see whether and how it gives exemestane. Its counts are asked again every night. How drug pages count

  1. 400Found by its intervention search · See all 400 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 290 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. −6
    Mention it without giving it — earlier treatment, a protocol code, a title naming another drug
  3. 394Give exemestane to participants
  4. −43Observe patients on it, or give it outside a trial
  5. −41Compare another treatment with it
  6. −193Give it beside what is tested
  7. 117Test it: the count on this site

Get an email when these change. Save the exemestane studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Oct 1999 · AROMASIN · NDA 020753 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Exemestane
70
Exemestane 25 MG
3
aromasil
3
exemestane (Aromasin)
3

Brand

Aromasin
34

Development codes

FCE-24304
11
PNU 155971
3

Studies by the year they started

115 studies that test it; most in 2001 (9)

Studies that test exemestane, by start year
YearStudies
19961
19982
19991
20002
20019
20025
20036
20045
20054
20061
20073
20085
20094
20102
20113
20124
20133
20143
20153
20166
20176
20184
20194
20203
20213
20223
20232
20245
20258
20265

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
62
Phase 3
38
Phase 4
7
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 102

Pfizer (9) · Fudan University (6) · ETOP IBCSG Partners Foundation (5) · National Cancer Institute (NCI) (4) · Spanish Breast Cancer Research Group (3) · NCIC Clinical Trials Group (3) · Memorial Sloan Kettering Cancer Center (3) · Roxane Laboratories (3)

Often tested with

Tested in the same studies.

Anastrozole (39) · Tamoxifen (21) · Letrozole (14) · Palbociclib (7) · Trastuzumab (6) · Capecitabine (5) · Hormone Therapy (5) · Goserelin (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 15 phase 3 studies under way

Exemestane is the comparator. A study of two new drugs counts under both.

  • 2Elacestrant · Stemline Therapeutics, Inc., European Organisation for Research and Treatment of Cancer - EORTC · next primary completion Aug 2029
  • 2Giredestrant · Genentech, Inc., Hoffmann-La Roche
  • 2AZD9833 · AstraZeneca · next primary completion Apr 2027
  • 2Imlunestrant · Eli Lilly and Company · next primary completion Oct 2027
  • 2HRS-8080 · Shandong Suncadia Medicine Co., Ltd. · next primary completion Aug 2027
  • 1Letrozole · Stemline Therapeutics, Inc. · next primary completion Aug 2029
  • 1Tamoxifen · Stemline Therapeutics, Inc. · next primary completion Aug 2029
  • 1Palazestrant · Olema Pharmaceuticals, Inc.
New treatments tested with it · 8 most studied

New when their studies opened, with exemestane beside them; studies of each.

Reaching primary completion within a year · 4

Studies that test exemestane.

Studies

Open first, then newest update. How each study uses exemestane has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 117

See all 117 studies that test exemestane →

Tested on its own · 33 — no other medicine in its arm

Showing 20 of 33. See all 33 →

Tested with established drugs · 7 — they are given beside it
Tested in a combination · 77 — another drug in the study is under test too

Showing 20 of 77. See all 77 →

Beside an established treatment under test · 33 — an approved drug, surgery or radiation is what the study tests

Tested with exemestane: Everolimus 7 · entinostat 4 · xentuzumab 2 · palbociclib 2 · Surgery or a procedure 1 · enzalutamide 1 · radium Ra 223 dichloride 1 · tucidinostat 1

Showing 20 of 33. See all 33 →

Beside a new treatment under test · 34 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with exemestane: entinostat 3 · Alpelisib 2 · tucidinostat 2 · ribociclib 2 · alobresib 2 · abemaciclib 1 · dalpiciclib 1 · E-7090 1

Showing 20 of 34. See all 34 →

Beside supportive care · 14 — a supportive treatment or test is studied
One option of several · 111 — a test or a strategy chooses among drugs

Showing 20 of 111. See all 111 →

Given beside what is tested · 1 — usual care or a partner of the new treatment
As the comparator · 41 — what is tested is compared with exemestane

Showing 20 of 41. See all 41 →

Observed · 43 — patients on it are followed, or it is given outside a trial

Showing 20 of 43. See all 43 →

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call exemestane · ClinicalTrials.gg INT003387

  • MeSH (NLM) C056516exemestaneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) NY22HMQ4BXEXEMESTANEConfirmed FDA, NLM, Wikidata
  • RxNorm 258494Confirmed FDA, Wikidata
  • Wikidata Q418819exemestaneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1097ExemestaneOne source FDA
  • DrugBank DB00990One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion